• [email protected]
  • +971 507 888 742
Submit Manuscript
SciAlert
  • Home
  • Journals
  • Information
    • For Authors
    • For Referees
    • For Librarian
    • For Societies
  • Contact
  1. International Journal of Pharmacology
  2. Vol 12 (7), 2016
  3. 720-728
  • Online First
  • Current Issue
  • Previous Issues
  • More Information
    Aims and Scope Editorial Board Guide to Authors Article Processing Charges
    Submit a Manuscript

International Journal of Pharmacology

Year: 2016 | Volume: 12 | Issue: 7 | Page No.: 720-728
DOI: 10.3923/ijp.2016.720.728

Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Article Trend



Total views 245

Authors


Qiaoyun Tong

Country: China

Yuanping Yang

Country: China

Zhange Xiong

Country: China

Zhongyan Li

Country: China

Wei Yuan

Country: China

Ting Wang

Country: China

Keywords


  • Chitooligosaccharides
  • ulcerative colitis
  • colonic inflammation
  • TLR4
  • NF-κB
  • COX-2
Research Article

Chitooligosaccharides Downregulate TLR4/NF-κB/COX-2 Signaling Cascade in Dextran Sulfate Sodium-treated Mice: A Potential Mechanism for the Anti-colitis Effect

Qiaoyun Tong, Yuanping Yang, Zhange Xiong, Zhongyan Li, Wei Yuan and Ting Wang
Background and Objective: The anti-inflammatory properties of chitooligosaccharides (COS), a new class of marine-derived natural products and functional foods have been well established, but the underlying mechanisms remain unclear. The aim of the present study is to investigate the effect and potential mechanisms of COS on colonic inflammation in a mouse model of experimental colitis induced by 3.5% Dextran Sulfate Sodium (DSS). Materials and Methods: Animals were randomly divided into 6 groups of 10 mice each: Normal group, model control COS treatment groups: Administered with COS at low (125 mg kg–1), middle (250 mg kg–1) and high (500 mg kg–1) oral administration dose once per day, respectively and positive control group: Salazosulfapyridine 50 mg kg–1. The mRNA and protein expression of toll-like receptor 4 (TLR4), nuclear factor kappa B (NF-κB) and cyclooxygenase (COX)-2 was measured in colon tissues using real-time PCR and immunofluorescence, respectively. Results: Oral administration of COS dose-dependently decreased bloody diarrhea event rate and the Disease Activity Index (DAI), attenuated the loss of body weight, shortening of colon length induced by DSS. Histological damage scores of the colon and colonic prostaglandin (PG)E2 content in DSS-treated mice were reduced by COS, suggesting the preventive effect of COS on the colonic inflammation. Importantly, it was found that the anti-colitis effect shown by COS appear to be related to their capacity to downregulate the expression of TLR4/NF-κB pathway, a canonical proinflamatory signalling, together with its downstream COX-2. Conclusion: The COS administration prevented the DSS-induced activation of TLR4/NF-κB/COX-2 signaling cascade in mouse colon. These finding could give insight into the further evaluation of COS as a food supplement or an alternative agent in the control of ulcerative colitis.
PDF Fulltext XML References Citation

How to cite this article

Qiaoyun Tong, Yuanping Yang, Zhange Xiong, Zhongyan Li, Wei Yuan and Ting Wang, 2016. Chitooligosaccharides Downregulate TLR4/NF-κB/COX-2 Signaling Cascade in Dextran Sulfate Sodium-treated Mice: A Potential Mechanism for the Anti-colitis Effect. International Journal of Pharmacology, 12: 720-728.

DOI: 10.3923/ijp.2016.720.728

URL: https://scialert.net/abstract/?doi=ijp.2016.720.728

Related Articles

Orally Administered Chitooligosaccharides Modulate Colon Microbiota in Normal and Colitis Mice
Bee Venom Reduces Fungi Induced Bronchial Epithelial Cells Activation Through Down Regulation of NF-κB

Leave a Comment


Your email address will not be published. Required fields are marked *

Useful Links

  • Journals
  • For Authors
  • For Referees
  • For Librarian
  • For Socities

Contact Us

Office Number 1128,
Tamani Arts Building,
Business Bay,
Deira, Dubai, UAE

Phone: +971 507 888 742
Email: [email protected]

About Science Alert

Science Alert is a technology platform and service provider for scholarly publishers, helping them to publish and distribute their content online. We provide a range of services, including hosting, design, and digital marketing, as well as analytics and other tools to help publishers understand their audience and optimize their content. Science Alert works with a wide variety of publishers, including academic societies, universities, and commercial publishers.

Follow Us
© Copyright Science Alert. All Rights Reserved